Brief: Inhalation Sciences Sweden Q4 Operating Loss Widens To SEK 2.0 Mln
Feb 20 (Reuters) - Inhalation Sciences Sweden AB ISAB.TE :
* Q4 NET SALES SEK 3.8 MILLION VERSUS SEK 3.9 MILLION YEAR
AGO
* Q4 OPERATING LOSS SEK 2.0 MILLION VERSUS LOSS SEK 1.4
MILLION
YEAR AGO
* PROPOSES NO DIVIDEND FOR FY 2019
Source text for Eikon: ID:nWkr1xjN7l
Further company coverage: ISAB.TE
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 772 0920;))
Recent news on Inhalation Sciences Sweden AB
See all newsBrief: Inhalation Sciences Gets Order Of EUR 60,000 From Long-Term Big Pharma Client
Brief: Inhalation Sciences Announces Outcome Of The Rights Issue
Brief: Inhalation Sciences Sweden Q4 Operating Loss Widens To SEK 4.3 Million
Brief: Inhalation Sciences Receives New Order From Aquilon Pharma
Brief: Inhalation Sciences Receives New Order From University Of Vienna